CONTEXT: Associations between menstrual cycle length and chronic diseases are hypothesized to be due to differences in underlying hormonal patterns. OBJECTIVE: The aim of the study was to evaluate the association between menstrual cycle length and the hormonal profile and anovulation. DESIGN AND SETTING: We conducted a prospective cohort study at the University at Buffalo from 2005 to 2007. PARTICIPANTS: We recruited 259 healthy, regularly menstruating women aged 18-44 yr. MAIN OUTCOME MEASURES: Cycle length was observed for up to two cycles. Serum estradiol, progesterone, LH, and FSH were measured up to eight times per cycle for up to two cycles. RESULTS: Women with short cycles (<26 d) had higher FSH concentrations during menses and in the late luteal phase, higher follicular estradiol concentrations, and lower LH concentrations across the cycle. Among women with longer cycles (>35 d), estradiol and LH peaks occurred on average about 3 d later, and FSH peaks about 1 d later compared to women with normal-length cycles. Both short and long cycles, compared with normal-length cycles, had an increased probability of anovulation. In general, per-cycle exposure to hormones was less in short cycles based on the area under the curve, although over time the cumulative exposure to estradiol would be greater for women with short cycles. CONCLUSIONS: Short ovulatory cycles were associated with higher follicular phase estradiol, an earlier rise in FSH, and an increased risk of anovulation. These results suggest that menstrual cycle length may be a relevant indicator of estradiol exposure and risk of anovulation among regularly cycling women.
CONTEXT: Associations between menstrual cycle length and chronic diseases are hypothesized to be due to differences in underlying hormonal patterns. OBJECTIVE: The aim of the study was to evaluate the association between menstrual cycle length and the hormonal profile and anovulation. DESIGN AND SETTING: We conducted a prospective cohort study at the University at Buffalo from 2005 to 2007. PARTICIPANTS: We recruited 259 healthy, regularly menstruating women aged 18-44 yr. MAIN OUTCOME MEASURES: Cycle length was observed for up to two cycles. Serum estradiol, progesterone, LH, and FSH were measured up to eight times per cycle for up to two cycles. RESULTS:Women with short cycles (<26 d) had higher FSH concentrations during menses and in the late luteal phase, higher follicular estradiol concentrations, and lower LH concentrations across the cycle. Among women with longer cycles (>35 d), estradiol and LH peaks occurred on average about 3 d later, and FSH peaks about 1 d later compared to women with normal-length cycles. Both short and long cycles, compared with normal-length cycles, had an increased probability of anovulation. In general, per-cycle exposure to hormones was less in short cycles based on the area under the curve, although over time the cumulative exposure to estradiol would be greater for women with short cycles. CONCLUSIONS: Short ovulatory cycles were associated with higher follicular phase estradiol, an earlier rise in FSH, and an increased risk of anovulation. These results suggest that menstrual cycle length may be a relevant indicator of estradiol exposure and risk of anovulation among regularly cycling women.
Authors: Sunni L Mumford; Enrique F Schisterman; Audrey J Gaskins; Anna Z Pollack; Neil J Perkins; Brian W Whitcomb; Aijun Ye; Jean Wactawski-Wende Journal: Paediatr Perinat Epidemiol Date: 2011-06-14 Impact factor: 3.980
Authors: C G Solomon; F B Hu; A Dunaif; J Rich-Edwards; W C Willett; D J Hunter; G A Colditz; F E Speizer; J E Manson Journal: JAMA Date: 2001-11-21 Impact factor: 56.272
Authors: Caren G Solomon; Frank B Hu; Andrea Dunaif; Janet E Rich-Edwards; Meir J Stampfer; Walter C Willett; Frank E Speizer; Joann E Manson Journal: J Clin Endocrinol Metab Date: 2002-05 Impact factor: 5.958
Authors: Peter M Meyer; Scott L Zeger; Siobán D Harlow; Maryfran Sowers; Sybil Crawford; Judith L Luborsky; Imke Janssen; Daniel S McConnell; John F Randolph; Gerson Weiss Journal: Am J Epidemiol Date: 2007-01-30 Impact factor: 4.897
Authors: Kathryn L Terry; Walter C Willett; Janet W Rich-Edwards; David J Hunter; Karin B Michels Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-06 Impact factor: 4.254
Authors: Penelope P Howards; Enrique F Schisterman; Jean Wactawski-Wende; Jennifer E Reschke; Andrea A Frazer; Kathleen M Hovey Journal: Am J Epidemiol Date: 2008-10-30 Impact factor: 4.897
Authors: Jean Wactawski-Wende; Enrique F Schisterman; Kathleen M Hovey; Penelope P Howards; Richard W Browne; Mary Hediger; Aiyi Liu; Maurizio Trevisan Journal: Paediatr Perinat Epidemiol Date: 2009-03 Impact factor: 3.980
Authors: Leslie V Farland; Fan Mu; A Heather Eliassen; Susan E Hankinson; Shelley S Tworoger; Robert L Barbieri; Mitch Dowsett; Michael N Pollak; Stacey A Missmer Journal: Cancer Causes Control Date: 2017-10-31 Impact factor: 2.506
Authors: Ankita Prasad; Sunni L Mumford; Germaine M Buck Louis; Katherine A Ahrens; Lindsey A Sjaarda; Karen C Schliep; Neil J Perkins; Kerri A Kissell; Jean Wactawski-Wende; Enrique F Schisterman Journal: Horm Behav Date: 2014-06-20 Impact factor: 3.587
Authors: Anna Z Pollack; Sunni L Mumford; Jenna R Krall; Andrea E Carmichael; Lindsey A Sjaarda; Neil J Perkins; Kurunthachalam Kannan; Enrique F Schisterman Journal: Environ Int Date: 2018-08-10 Impact factor: 9.621
Authors: Katherine Ahrens; Sunni L Mumford; Karen C Schliep; Kerri A Kissell; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman Journal: Am J Obstet Gynecol Date: 2013-11-08 Impact factor: 8.661
Authors: Raina D Pang; Madalyn M Liautaud; Matthew G Kirkpatrick; Jimi Huh; John Monterosso; Adam M Leventhal Journal: Neuropsychopharmacology Date: 2017-09-14 Impact factor: 7.853
Authors: Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen Journal: Am J Epidemiol Date: 2016-04-15 Impact factor: 4.897